Autor(es): Voltz R,Hohlfeld R

Resumo: Intravenous immunoglobulin is increasingly used in the treatment of neuromuscular disorders. Its efficacy has been proven in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and Lambert-Eaton myasthenic syndrome. In addition, there is increasing evidence that it has beneficial effects in other neuromuscular disorders.

Imprenta: Current Opinion in Neurology, v. 9, n. 5, p. 360-366, 1996

Descritores: Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies

Data de publicação: 1996

INDICADORES

ACESSO